糖尿病、糖尿病前期与MRI上的脑体积及亚临床脑血管病变:社区动脉粥样硬化风险神经认知研究(ARIC-NCS)
该横断面研究纳入1713名参与者,按HbA1c和糖尿病病程分组,分析其与脑体积和血管病变的关联。结果显示,仅HbA1c≥7.0%的糖尿病和病程≥10年与脑体积减小及血管病变负担增加相关,糖尿病前期和HbA1c<7.0%的糖尿病无显著关联。未发现脑血管病变介导糖尿病与脑体积的关联。
要点
- HbA1c≥7.0%的糖尿病与全脑及区域脑体积减小、白质高信号负担增加相关。
- 糖尿病病程≥10年与脑体积减小及腔隙灶负担增加相关。
- 糖尿病前期和HbA1c<7.0%的糖尿病与脑体积及血管病变无显著关联。
核心结论
- 更严重的糖尿病(由较高HbA1c和较长病程定义)而非糖尿病前期或较轻糖尿病与脑体积减小和脑血管病变负担增加相关。
- 未发现脑血管病变介导糖尿病与脑体积减小的关联,提示其他机制可能负责这些关联。
研究设计与样本
- 横断面研究,纳入社区动脉粥样硬化风险神经认知研究(ARIC-NCS)中2011-2013年接受3T脑MRI扫描的1713名参与者。
- 参与者平均年龄75岁,60%女性,27%黑人,30%糖尿病前期,35%糖尿病。
- 按糖尿病-HbA1c状态分组:无糖尿病(HbA1c<5.7%[参照])、糖尿病前期(HbA1c 5.7至<6.5%)、糖尿病(既往诊断或HbA1c≥6.5%)且HbA1c<7.0% vs ≥7.0%,并进一步按糖尿病病程(<10 vs ≥10年)分层。
主要发现
- 与无糖尿病且HbA1c<5.7%的参与者相比,糖尿病前期和糖尿病且HbA1c<7.0%的参与者脑体积或血管病变无显著差异(所有P>0.05)。
- 与无糖尿病且HbA1c<5.7%的参与者相比,糖尿病且HbA1c≥7.0%的参与者全脑体积较小(β -0.20 SDs,95% CI -0.31至-0.09),区域脑体积较小(包括额叶、颞叶、枕叶和顶叶;深部灰质;阿尔茨海默病特征区域;和海马[所有P<0.05]),白质高信号(WMH)负担增加(P=0.016)。
- 在糖尿病参与者中,HbA1c≥7.0%者与HbA1c<7.0%者相比,全脑和区域脑体积较小且WMH负担增加(所有P<0.05)。
- 糖尿病病程≥10年者与病程<10年者相比,脑体积较小且腔隙灶负担较高(所有P<0.05)。
- 结构方程模型未发现WMH介导糖尿病与脑体积较小关联的证据(所有P>0.05)。
关键数值与推荐
- 糖尿病前期定义为HbA1c 5.7至<6.5%。
- 糖尿病定义为既往诊断或HbA1c≥6.5%,并按HbA1c<7.0% vs ≥7.0%分层。
- 糖尿病病程按<10年 vs ≥10年分层。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the associations of prediabetes, diabetes, and diabetes severity (as assessed by HbA1c and diabetes duration) with brain volumes and vascular pathology on brain MRI and to assess whether the associations of diabetes with brain volumes are mediated by brain vascular pathology. RESEARCH DESIGN AND METHODS: Cross-sectional study of 1,713 participants in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) (mean age 75 years, 60% female, 27% black, 30% prediabetes, and 35% diabetes) who underwent 3T brain MRI scans in 2011-2013. Participants were categorized by diabetes-HbA1c status as without diabetes (<5.7% [reference]), with prediabetes (5.7 to <6.5%), and with diabetes ([defined as prior diagnosis or HbA1c ≥6.5%] <7.0% vs. ≥7.0%), with further stratification by diabetes duration (<10 vs. ≥10 years). RESULTS: In adjusted analyses, compared with participants without diabetes and HbA1c <5.7%, participants with prediabetes and those with diabetes and HbA1c <7.0% did not have significantly different brain volumes or vascular pathology (all P > 0.05), but those with diabetes and HbA1c ≥7.0% had smaller total brain volume (β -0.20 SDs, 95% CI -0.31, -0.09), smaller regional brain volumes (including frontal, temporal, occipital, and parietal lobes; deep gray matter; Alzheimer disease signature region; and hippocampus [all P < 0.05]), and increased burden of white matter hyperintensities (WMH) (P = 0.016). Among participants with diabetes, those with HbA1c ≥7.0% had smaller total and regional brain volumes and an increased burden of WMH (all P < 0.05) compared with those with HbA1c <7.0%. Similarly, participants with longer duration of diabetes (≥10 years) had smaller brain volumes and higher burden of lacunes (all P < 0.05) than those with a diabetes duration <10 years. We found no evidence for mediation by WMH in associations of diabetes with smaller brain volumes by structural equation models (all P > 0.05). CONCLUSIONS: More-severe diabetes (defined by higher HbA1c and longer disease duration) but not prediabetes or less-severe diabetes was associated with smaller brain volumes and an increased burden of brain vascular pathology. No evidence was found that associations of diabetes with smaller brain volumes are mediated by brain vascular pathology, suggesting that other mechanisms may be responsible for these associations.
引用
- Schneider ALC, Selvin E, Sharrett AR, et al. Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Diabetes Care. 2017. PMID: 28916531. doi:10.2337/dc17-1185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。